000 | 01808 a2200469 4500 | ||
---|---|---|---|
005 | 20250514031328.0 | ||
264 | 0 | _c20020613 | |
008 | 200206s 0 0 eng d | ||
022 | _a1462-0324 | ||
024 | 7 |
_a10.1093/rheumatology/41.4.458 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKnijff-Dutmer, E A J | |
245 | 0 | 0 |
_aPlatelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. _h[electronic resource] |
260 |
_bRheumatology (Oxford, England) _cApr 2002 |
||
300 |
_a458-61 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xblood |
650 | 0 | 4 | _aBleeding Time |
650 | 0 | 4 |
_aBlood Platelets _xdrug effects |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMeloxicam |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNaproxen _xtherapeutic use |
650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 |
_aThiazines _xtherapeutic use |
650 | 0 | 4 |
_aThiazoles _xtherapeutic use |
650 | 0 | 4 |
_aThromboxane B2 _xblood |
700 | 1 | _aKalsbeek-Batenburg, E M | |
700 | 1 | _aKoerts, J | |
700 | 1 | _avan de Laar, M A F J | |
773 | 0 |
_tRheumatology (Oxford, England) _gvol. 41 _gno. 4 _gp. 458-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/41.4.458 _zAvailable from publisher's website |
999 |
_c11863570 _d11863570 |